Lessons from Multiple Infections Such as Lymphoma Complicated with Pneumocystis Infection: A Case Report

Figures & data

Figure 1 Serial chest CT scans at D1, D10, and D30 during the anti-infection period: (A) the initial CT scan at D1 showed an increased texture of both lungs increased, with multiple slight exudations and a small pleural effusion; (B) CT scan on D10 after admission revealed multiple progressive patchy shadows on both lungs, with ground-glass opacities and inflammatory exudates; (C) the follow-up CT scan on D30 after admission showed resolution of the bilateral diffuse patchy shadows, and increased multiple nodules increased in both lungs, with no pleural effusion. CT, computed tomography.

Table 1 Changes in the Main Indices During the Anti-Infection Period

Date	CRP mg/L	PCT ng/mL	WBC 10^9/L	LDH U/L	ALT U/L
D1	30.46	0.28	3.6	860	38
D3			3.3
D4	63.34			546	78
D5			3.4
D6	117.51	0.39		474	269
D8			3.0
D10	167.53	5.32	2.7	564	139
D12	121.6	1.8	3.1	463	88
D15	30.3	0.39		487	52

Abbreviations: CRP, C-reactive protein; PCT, procalcitonin; WBC, white blood cell; LDH, lactate dehydrogenase; ALT, alanine aminotransferase.

Figure 2 Temperature trend chart and anti-infection summary during the hospital stay. Trimethoprim-sulfamethoxazole (TMP-SMX) 1.44 g qid (D1−D6) and 0.96 g qid (D7−D30), micafungin 0.2 g qd (D7−D10), caspofungin 50 mg qd (D11−D30), HRLfx (D1−D10) [R(rifampicin) 0.6 g qd, H(isoniazid) 0.3 g qd and Lfx(levofloxacin) 0.5 g qd], meropenem 1 g q8h (D1−D14), cefoperazone-sulbactam 2 g q8h (D15−D21) and teicoplanin 400 mg qd (D10-D17).

Data Sharing Statement

Data will be provided by the corresponding author upon reasonable request.